The cost-effectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE study.

Andre Lamy; Bengt Jönsson; William S Weintraub; Feng Zhao; Susan Chrolavicius; Ameet Bakhai; Steven Culler; Amiram Gafni; Peter Lindgren; Elizabeth Mahoney

doi:10.1097/01.hjr.0000152239.28456.36

The cost-effectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE study.

Identifier:nobleid.org/w1/20260515/C4F93F08

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C4F93F08.svg?ark=w1%2F20260515%2FC4F93F08)](https://nobleid.org/work/w1/20260515/C4F93F08)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

The cost-effectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE study.

Identifier:nobleid.org/w1/20260515/C4F93F08

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C4F93F08.svg?ark=w1%2F20260515%2FC4F93F08)](https://nobleid.org/work/w1/20260515/C4F93F08)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work